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 Adiponectin (Adipoq) ameliorates cellular senescence in the white 
adipose tissue. 
 Adipoq increases insulin sensitivety. 
 Adipoq increases survival over endotoxin shock. 
 These effects of Adipoq are similar to those induced by calorie restriction 
(CR). 
 Adipoq does not inhibit tumor growth, incontrast to CR. 
Abstract 
 
Adiponectin (Adipoq), a peptide hormone secreted from the white adipose 
tissue, may play a role in the anti-aging and/or anti-tumor effects of calorie 
restriction (CR). We analyzed metabolic traits in Adipoq gene-overexpressing 
mice fed ad libitum with a regular diet (RD) or a high-fat diet (HFD), or fed 
30% CR of RD initiated at 12 weeks of age. Adipoq-RD and -HFD mice at 6 
months of age showed reduced blood glucose and insulin concentrations, and 
thus increased insulin sensitivity, compared with WT mice fed a RD or a HFD. 
In the epididymal white adipose tissue in Adipoq mice, senescence-like 
changes such as upregulation of p53 protein and of biomarkers of 
inflammation, Cd68 and Ccl2 mRNA, were ameliorated compared with WT-
RD and WT-HFD mouse tissues. Resistance to stress induced by 
lipopolysaccharide was also strengthened in Adipoq mice compared with WT 
mice. These metabolic changes and stress resistance were also noted in the 
WT-CR mice, suggesting that Adipoq plays a part in the effect of CR. In 
contrast, in an allograft tumor growth model, tumor growth was not inhibited 
in Adipoq mice. The present findings suggest that Adipoq plays a part in the 
anti-aging, but not in the anti-tumor, effects of CR. 
 
Keywords: Adiponectin, Calorie restriction, p53, Insulin, ER stress,  
Tumor growth   
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1. Introduction 
Modest restriction of dietary calorie intake (with sufficient supply of 
essential nutrients) extends lifespan and inhibits diseases including cancers 
in aging animals (Weindurch and Walford 1988). This experimental paradigm 
has been a tool to investigate signaling pathways that regulate lifespan and 
aging. Although many researchers have investigated this phenomenon, our 
knowledge on the pathways involved remains incomplete. 
Long-term calorie restriction (CR) is thought to promote metabolic 
adaptation in animals for survival, i.e., increase energy efficiency to maintain 
basic physiological functions with limited energy intake. This adaptive 
process, which copes with aging-related insulin resistance and glucose 
intolerance, may play a part in the effect of CR (Masoro, 2003). Among 
candidates that promote the metabolic adaptation, we have focused on 
adiponectin (Adipoq), which is secreted from white adipose tissues (WAT: Hui, 
2012). The plasma concentration of Adipoq is increased in CR rodents in 
parallel with reduction of fat mass (Berg, 2001; Zhu, 2004). Increased plasma 
Adipoq is known to be associated with insulin-sensitizing, anti-diabetic, and 
anti-atherosclerotic effects (Hui, 2012). Finally, overexpression of the human 
Adipoq gene is reported to extend the lifespan of mice; not only those fed a 
high-fat diet (HFD) but also those fed a regular diet (RD: Otabe, 2007). 
Therefore, we can speculate that CR exerts a life-extending effect through the 
metabolic adaptation process, which upregulates Adipoq in the WAT and thus 
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in the circulation. 
Excess calorie intake in mice, either genetically-induced or resulting 
from dietary changes, leads to the accumulation of oxidative stress in the 
WAT and promotes senescence-like changes including increased expression of 
p53 and production of proinflammatory cytokines in the WAT (Minamino, 
2009). Concomitantly, whole body insulin resistance and glucose intolerance 
occur in mice; these impairments are ameliorated by inhibition of p53 in the 
WAT (Minamino, 2009). In the present study, to understand the molecular 
mechanisms underlying the effect of CR on insulin and glucose homeostasis, 
we first tested whether or not Adipoq overexpression ameliorates the 
senescence-like phenotypes in the WAT in parallel with insulin sensitization. 
We then assessed stress resistance in Adipoq mice, because CR is 
known to enhance resistance to a variety of stressors (Masoro, 1998). In the 
present study, survival rates and endoplasmic reticulum (ER) stress were 
monitored in an endotoxin shock mouse model. 
Inhibition of tumor growth is another hallmark of the effects of CR 
(Weindruch, 1988). The plasma Adipoq concentration is reported to be 
inversely associated with a variety of human cancers (Barb, 2007), and these 
findings correlate with the increased risk of cancers in obese people. We 
therefore also tested whether or not overexpression of Adipoq inhibits tumor 
growth in an allograft tumor growth model (Yaker, 2006). 
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2. Materials and methods 
 
2.1. Experimental Animals 
The animal care and all experiments were performed in accordance 
with the guidelines approved by the Ethics Review Committee for Animal 
Experimentation at Nagasaki University. Pairs of human Adipoq gene 
overexpressing homozygotic mice and the appropriate wild-type (WT) mice 
(C57BL/6N) were transferred to the Laboratory animal center at Nagasaki 
University from Kurume University, where the original SPF colony of Adipoq 
and WT mice is maintained (Otabe, 2007). 
The details of animal husbandry were as described elsewhere 
(Yamaza, 2010). Briefly, two or three (typically three) mice were housed in a 
cage in a barrier facility (temperature, 22–25°C; 12-h light/dark cycle) under 
specific pathogen-free conditions. Male Adipoq and WT mice were fed a 
regular diet (RD, Charles River-LPF (CR-LPF) diet, Oriental Yeast Co. Ltd., 
Tsukuba, Japan) until 12 weeks of age. The composition of the CR-LPF diet, 
which is based on the formula of the Charles-River formula (CRF)-1 diet but 
with reduced protein content and reduced total energy for long-term 
experiments to minimize aging-related disorders (Shumiya, 1993), was as 
follows (per 100 g; 347 kcal): 16.5-g protein, 3.9-g fat, 5.9-g mineral mix, 4.4-
g fiber, 61.3-g nitrogen-free water-soluble substance, and 8.0-g water. 
Thereafter, mice were divided into two groups, a RD group and a 
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high-fat diet (HFD, i.e., F2HFD1 diet, Oriental Yeast Co. Ltd.: 414 kcal/100 
g) group. The composition of the HFD was as follows (per 100 g): 7.5-g Cacao 
butter, 1.25-g cholesterol, 0.5-g cholic acid sodium salt, 7.5-g milk casein, 1.25-
g cellulose, 1.0-g vitamin mix, 1.0-g mineral mix, 1.625-g sucrose, 1.625-g 
glucose, 1.625-g dextrin, 0.125-g choline chloride, 72-g CRF-1, 3-g lard). In 
summary, the macronutrient content of the HFD diet was as follows (per 100 
g; 414 kcal); 22.6-g protein, 16.5-g fat, and 45.1-g carbohydrates. These mice 
were fed ad libitum. A calorie-restricted (CR) group, in which WT mice were 
fed the RD diet at a level 30% less than the ad libitum level of mice in the 
WT-RD group, was also included. At 12 weeks of age, the CR regimen was 
initiated by providing the CR animals with a daily food allocation consisting 
of 70% of the mean daily ad libitum food intake of the WT-RD mice, 30 min 
before lights were turned off; on Saturday, two portions of food (for Saturday 
and Sunday) were provided. The food allocation for the WT-CR group was 
adjusted every 4 weeks depending on the amount of food consumed by the 
WT-RD group. The daily amount of food consumed by a single mouse was 
estimated by the total amount of food consumed in each cage, in which three 
mice were housed, divided by the number of mice in the cage.  
Body weight (BW) and food intake were monitored every 4 weeks 
from 6 weeks of age. Mice were humanely euthanized after anesthesia with 
isoflurane between 24 and 28 weeks for the experiments.  
ER stress-responsive alkaline phosphatase (ESTRAP) mice 
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(Kitamura, 2011) were used to monitor ER stress in vivo. Pairs of ESTRAP 
heterozygotic mice, in which secreted alkaline phosphatase (SEAP) is 
constitutively expressed, were transferred from the University of Yamanashi. 
The genetic background was C57BL/6. Male and female ESTRAP mice were 
mated to expand the experimental mouse colony. To determine the genotype 
of the offspring, genomic DNA was extracted from the tail using a DNeasy 
Blood & Tissue Kit (Qiagen, Hilden, Germany) and PCR was performed with 
SEAP-specific primer as follows: forward: 5′-
AACATGGACATTGACGTGATCCTAG-3′; reverse: 5′-
TCTCGTATTTCATGTCTCCAGGCTC-3′ (Hiramatsu, 2006). Male ESTRAP 
heterozygous mice and female Adipoq homozygous or heterozygous mice were 
mated to produce double transgenic (Adipoq:ESTRAP) as well as wild type 
(WT:ESTRAP) mice. The 30% CR regimen was also initiated in these mice at 
12 weeks of age. 
 
2.2. Hormone and glucose assays 
Plasma and serum samples were prepared from blood samples 
collected via cardiac puncture after anesthesia with isoflurane. These 
samples were collected 3 hours prior to feeding (thus in the fasting phase) for 
the CR group; for the ad libitum feeding groups, mice were fasted overnight 
(approximately 17 hours fasting) prior to sample collection. The plasma 
concentrations of human and mouse adiponectin were measured with specific 
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ELISA kits for human and mouse/rat adiponectin (Otsuka Pharmaceutical Co. 
Ltd., Tokushima, Japan), respectively, without detectable cross-reactivity. 
The mouse plasma leptin and serum insulin levels were also determined 
using ELISA kits (Shibayagi Co. Ltd., Gumma, Japan). Blood glucose levels 
were measured using the glucose dehydrogenase method. The number of mice 
in each group was 8, except for WT-CR (n = 5). 
To estimate insulin sensitivity, the quantitative insulin-sensitivity 
check index (Quicki; Muniyappa, 2008) was calculated using fasting serum 
insulin (I0) and glucose (G0) according to the following formula; Quicki = 
1/[log(I0) + log(G0)]. Thus, larger values of Quicki represent greater insulin 
sensitivities. The Quicki has been validated extensively against the reference 
standard glucose clamp method (Muniyappa, 2008).  
 
2.3. Western blotting for p53 and p21 
Approximately 200 mg of frozen fat tissues were homogenized in 800 
mL T-PER buffer (PIERCE Biotechnology, Rockford, IL, USA) with a 
protease-inhibitor cocktail (P8340 Sigma-Aldrich, St. Louis, MO, USA) and a 
phosphatase-inhibitor cocktail (Nacalai Tesque Inc., Kyoto, Japan). The 
homogenates were centrifuged at 10000 × g for 15 min at 4°C, and the 
supernatant was collected. Protein concentrations were measured using the 
BCA assay kit (PIERCE Biotechnology). For detection of p53, 
immunoglobulins were removed from total protein lysates with protein A/G 
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agarose (PIERCE Biotechnology), following the method published by 
Minamino et al. (2009). All samples were mixed with Laemmli’s sample buffer 
and heated at 95°C for 5 min. Proteins (10 µg) were separated by 10 or 15% 
SDS-PAGE and transferred to PVDF membranes. The membranes were 
immediately placed in blocking solution (PVDF Blocking Reagent for Can Get 
Signal®: TOYOBO, Osaka, Japan) for 60 min. The membranes were incubated 
with anti-p53 mouse monoclonal antibody (Cell Signaling Technology 
Denvars, MA, #2524) diluted at 1:500 in immunoreaction enhancer solution 
(Can Get Signal® solution 1, TOYOBO) for 16 h at 4°C with gentle shaking, 
and washed 3 times in TBS-T. The membranes were then incubated for 1 h 
with HRP-conjugated anti-mouse IgG (GE Health Care) diluted 1:10,000 in 
immunoreaction enhancer solution. Immunoreactive proteins were visualized 
using ECL (Amersham Biosciences, Tokyo, Japan) and quantified using a 
densitometer (LAS-3000: Fuji Film, Tokyo, Japan) and MultiGauge software 
(Fuji Film). To minimize variations in signal intensity, a standard sample of 
p53 was included in each blot. The number of mice in each group was 3. 
 
2.4. Real-time PCR for determination of mRNA levels 
Total RNA was purified from the epididymal adipose tissue using an 
RNeasy lipid tissue mini kit and RNase-Free DNase Set (QIAGEN) and 
quantified by spectrophotometry (NanoDrop, Wilmington, DE). The quality 
of extracted RNA was evaluated as the densitometric ratio of 28S and 16S 
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ribosomal RNA. The extracted RNA was reverse-transcribed using a Bio-Rad 
iScriptTM cDNA Synthesis kit (Hercules, CA, USA) according to the 
manufacturer’s instructions. The real-time PCR reaction was performed 
using Platinum® Quantitative PCR SuperMix-UDG with ROX (Invitrogen) 
and primers and fluorescent probes sets. Primers and fluorescent probes sets 
(TaqMan Gene Expression Assays) were purchased from Applied Biosystems: 
human adiponectin (ADIPOQ; Hs00605917_m1), mouse adiponectin (Adipoq; 
Mm01343606_m1), Adipor1 (Mn01291334_mH), Adipor2 (Mn01184032_m1), 
Cd68 (Mm03047340_m1), Ccl2 (Mn00441242_m1), Leptin (Lep; 
Mm00440181_m1), Ppara (Mm00440939_m1), Pparg (Mm01184322_m1), 
Ppargc1a (Mm01208835_m1), Glut4 (Mm01245502_m1), Fatp1 
(Mm00449511_m1), actin beta (Actb; Mm02619580_g1), and Eukaryotic 18S 
rRNA (Hs99999901_s1). 
The amount of mRNA for the gene of interest in each sample was 
normalized to that of the housekeeping gene [actin beta (Actb) or 18S rRNA]. 
All samples ware run in duplicate on the ABI PRISM 7900HT Sequence 
Detector system (Applied Biosystems). The number of mice in each group was 
8, except for WT-CR (n = 5). Tissues were collected without fasting; in CR 
mice, tissues were collected within 3 hours of the provision of food, i.e., during 
the fed phase. 
 
2.5. Endotoxin shock and SEAP assay 
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 Between the period of 24 and 28 weeks of age, endotoxin shock was 
induced in (Adipoq:ESTRAP)-RD mice and control (WT:ESTRAP) mice, fed 
RD ad libitum or at 30% CR, by intraperitoneal injection of a single dose (10 
mg/kg BW) of lipopolysaccharide (LPS, Escherichia coli O111:B4, Product 
Number L2630, Sigma). After LPS injection, mice were inspected twice daily 
for 5 days. Blood samples were collected from retro-orbital veins at 0, 2, 4, 8, 
24, and 48 h after LPS injection to measure SEAP activity. The SEAP 
detection assay was performed using the phospha-Light-EXP SEAP reporter 
gene assay system (Life Technologies) according to the manufacturer's 
instructions. In brief, an aliquot of 5 µL serum was mixed with 50 µL of assay 
buffer in a white 96-well assay plate and incubated at 65°C for 5 min. Then, 
50 µL of reaction buffer was added and the mixture was incubated at room 
temperature for 20 min. The chemiluminescence was determined using a 
Synergy 2 Microplate Reader (BioTek, Tokyo, Japan). The number of mice in 
each group was 7. 
 
2.6. Allograft tumor growth model  
To evaluate the effect of Adipoq on tumor growth, 24-week-old mice 
were injected subcutaneously with 0.5 × 106 tumor cells (H-59 Lewis lung 
carcinoma cells), and monitored daily for 16 days. We followed the 
experimental procedure reported elsewhere (Yakar, 2006). The numbers of 
mice in the experimental groups were as follows; n = 9 for WT-RD and Adipoq-
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RD; n = 10 for WT-HFD; and n = 8 for Adipoq-HFD.  
 
2.7. Statistics 
 Data are presented as means ± standard error. One- or two-factor 
analysis of variance (ANOVA) and post hoc tests (Hsu-Dunnett or Tukey’s 
honestly significant difference (HSD) tests) were applied for data analyses. 
Survival curves were estimated using the Kaplan-Meier method and were 
compared with the log-rank test. A p value of less than 0.05 was considered 
to be statistically significant. All statistical tests were performed using JMP® 
Pro 10.0.2 statistical software (SAS Institute Inc., Cary, NC, USA).  
 
3. Results and Discussion 
 
3.1. General properties of experimental mice 
Mean BW of Adipoq-RD mice did not significantly differ from that of 
WT-RD mice (Fig. 1A). Mean food consumption (FC) of Adipoq-RD mice was 
also not significantly different from that of WT-RD mice (Fig. 1B). Mean BW 
of mice in the WT-HFD group was significantly greater than that in the WT-
RD (Fig. 1A), i.e., WT mice showed a diet-induced obesity phenotype. However, 
Adipoq-HFD mice did not show any significant increase in BW compared with 
Adipoq-RD mice (Fig. 1A), although the FC of Adipoq-HFD mice was similar 
to that of WT-HFD mice (Fig. 1C). These findings have already been noted in 
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the original report describing these mice (Otabe, 2007). Adipoq mice are 
known to increase oxygen consumption rate and decrease body fat content, 
particularly in response to high calorie diet feeding (Otabe, 2007). In the 
present study, we found that even when fed the RD, the fat content (peri-renal 
and epididymal fat) of Adipoq mice was less than that of WT mice (0.011 ± 
0.001 g/ g BW in Adipoq mice versus 0.044 ± 0.004 g/ g BW in WT mice, p < 
0.0001). Thus, Adipoq overexpression increased energy expenditure even in 
mice fed the RD, although the effect was minor compared with that seen in 
response to HFD feeding. In the genetic background of ESTRAP mice, 
Adipoq:ESTRAP-RD mice displayed slightly lower BW between 12 and 24 
weeks of age, compared with WT:ESTRAP-RD mice (2f ANOVA, p < 0.0001; 
Fig. 1D), although there was no statistical difference in BW at individual time 
points. Mean BW of WT:ESTRAP-CR mice was also significantly lower than 
that of WT:ESTRAP-RD mice in response to the 30% reduction of food intake 
(Fig. 1D). 
 Human Adipoq was detected in Adipoq mice (447 ± 52 µg/mL), but 
not in WT mice. Mouse Adipoq was increased in Adipoq mice compared with 
WT mice (92.7 ± 7.1 µg/mL in Adipoq mice versus 55.7 ± 2.5 µg/mL in WT 
mice, p < 0.0001).  
 
3.2. Insulin and glucose homeostasis 
We also confirmed that Adipoq-RD and Adipoq-HFD mice have lower 
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insulin concentrations compared with the respective WT mice (p = 0.0303 and 
p = 0.0004, respectively, Table 1). WT-CR mice also exhibited 56% lower levels 
of insulin compared with WT-RD mice (p = 0.006). The fasting blood glucose 
concentration of Adipoq-RD mice did not differ from that of WT-RD mice 
(Table 1). Blood glucose was lower in Adipoq-HFD than in WT-HFD mice (p < 
0.0001), although blood glucose was increased in WT-HFD mice compared 
with WT-RD mice (p < 0.0001). CR reduced the blood glucose concentration in 
WT mice (152 ± 6 mg/dL in WT-RD versus 110 ± 5 mg/dL in WT-CR, p < 
0.0001). Quicki analysis (Muniyappa, 2007) indicated that insulin sensitivity 
was significantly increased in Adipoq-RD and Adipoq-HFD mice compared 
with the respective WT mice (p = 0.0084 and p < 0.0001), as was the case in 
WT-CR mice (p < 0.0001; Table 1). These findings indicate that Adipoq 
overexpression mimics the effect of CR on insulin and glucose homeostasis. 
 
3.3. Cellular senescence-like changes in the WAT 
Excessive calorie intake has been reported to induce cellular 
senescence-like changes such as expression of p53 and inflammation in the 
WAT (Minamino, 2009). Inhibition of p53 activity in the WAT markedly 
ameliorates the senescence-related changes and inflammation, and improves 
insulin resistance and glucose intolerance (Minamino, 2009). In the present 
study, p53 protein abundance and the downstream p21 protein levels in the 
epididymal adipose tissue were significantly reduced in Adipoq-RD and 
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Adipoq-HFD mice, compared with WT-RD and WT-HFD mice (p53; p = 0.0004, 
p < 0.0001, p21; p < 0.0001, p = 0.0004); there was no difference between WT-
RD and WT-HFD mice (Fig. 2A, B, & C). The expression levels of p53 and p21 
were also lower in WT-CR mice than in WT-RD mice (p53; p = 0.0002, p21; p 
< 0.0001). We also confirmed that mRNA levels of the proinflammatory genes 
Cd68 and Ccl2 were reduced in the WAT of Adiopoq-RD and Adipoq-HFD mice, 
compared with WT-RD and WT-HFD mice (Cd68; p = 0.0062, p = 0.0003, Ccl2; 
p = 0.0006, p = 0.0180; Fig. 2D & E); there was no difference between WT-RD 
and WT-HFD or between Adipoq-RD and Adipoq-HFD mice. There was a 
significant reduction in the expression of these proinflammatory genes in WT-
CR mice compared with WT-RD mice (p = 0.0002, p < 0.0001). Therefore, the 
present findings indicate that Adipoq and CR ameliorate senescence-like 
changes in the WAT, leading to increased insulin sensitivity and glucose 
tolerance.  
 
3.4. Gene expression in WAT associated with energy metabolism  
 To further characterize the properties of WAT in Adipoq mice, we 
analyzed the expression of mRNA encoded by genes associated with energy 
metabolism, adipokines, and adipogenesis (Fig. 3). Expression of these genes 
has been reported to be significantly altered by CR (Higami, 2004; Park, 2009). 
The mRNA expression level of mouse Adipoq was increased by 30% in Adipoq-
RD and Adipoq-HFD mice, as well as in WT-CR mice, compared with WT-RD 
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and WT-HFD mice (Fig. 3A, p = 0.0029, Adipoq-RD versus (vs) WT-RD; p = 
0.0260, Adipoq-HFD vs WT-HFD; p = 0.0081, WT-CR vs WT-RD, respectively). 
There was no difference between WT-RD and WT-HFD or between Adipoq-
RD and Adipoq-HFD mice. Thus, overexpression of human Adipoq mimics the 
effect of CR on WAT with respect to endogenous adiponectin expression, 
probably through reduction of fat mass. In fact, not only the reduction of net 
amounts of fat pads but also fat cell size was smaller in Adipoq-RD and 
Adipoq-HFD mice than in the respective WT mice (Supplemental Fig. 2). One 
of the specific receptors for Adipoq, Adipor2 (but not Adipor1), showed 
significantly increased mRNA expression levels in Adipoq-RD and Adipoq-
HFD mice, compared with WT-RD and WT-HFD mice (p = 0.0036, p < 0.0001; 
Fig. 3B & C). The Adipor2-mRNA level was also increased in WT-CR mice 
compared with WT-RD mice (p < 0.0001). There was no difference between 
WT-RD and WT-HFD or between Adipoq-RD and Adipoq-HFD mice. Adipoq 
mice and WT-CR mice showed reduced mRNA levels of mouse leptin (p < 
0.0001; Fig. 3D). These changes of Adipoq and leptin coincide with protection 
of the animals from metabolic disorders such as diabetes (Cao, 2014). 
 Although many of the published data indicate an increase of Adipoq 
by CR in the peripheral blood, it should be noted that the effect of CR on 
plasma Adipoq and/or Adipoq mRNA expression in the WAT depends on 
experimental settings. In the epididymal fat tissue of control mice for long-
lived Ames dwarf mice, Adipoq mRNA expression levels are significantly (2.3-
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fold) increased by 8-month-long 30% CR initiated at 3 months of age 
(Wiesenborn, 2014). The plasma adiponectin concentration in CR mice was 
also significantly elevated, compared with control mice fed ad libitum. 
However, 16-months’ CR does not significantly increase the plasma 
concentration or the mRNA level of Adipoq in the epididymal fat tissue (Wang, 
2006). A 25% CR regimen using a diet formulated to be isocaloric with the 
control diet (American Institute Nutrition (AIN)-93M diet) with 25% 
increases in protein, vitamin, mineral and fat content did not elevate the 
plasma Adipoq concentration in mice of a mammary tumor model during a 
64-week-long experiment (Dogan, 2010). In that experiment, the body weight 
and visceral fat pads in female mice were decreased by the CR regimen, 
compared with mice fed the control diet ad libitum. We presume that CR mice 
in that experiment received relatively greater amounts of protein compared 
with WT-CR mice in the present study. Therefore, the age of mice and/or 
duration of the CR regimen, as well as diet composition, may affect the 
expression level of Adipoq mRNA in the WAT, and thus plasma concentrations 
of Adipoq, under CR conditions. 
 In contrast, in the present experiment, HFD feeding did not affect 
the expression level of mouse Adipoq mRNA in the WAT in WT mice, when 
compared with the RD feeding, although the HFD feeding induced obesity. 
The present findings are in accord with those reported by Qiao et al. (Qiao, 
2011). Although fasting glucose levels were significantly elevated in WT-HFD 
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compared with WT-RD mice, the insulin sensitivity assessed by Quicki did 
not significantly differ between the two groups. An experiment using male 
C57BL/6J mice in experimental settings (age of mice and duration of the 
experiment) similar to the present study demonstrated that a high fat diet 
induced obesity with a significant reduction of Adipoq mRNA in the WAT 
while not affecting the plasma Adipoq (Barnea, 2006). The calories from fat 
in the HFD in the present study were 36%, whereas this was 42% in the study 
reported by Barnea. The sources of fat were also different; cacao butter and 
lard in the present study but soybean oil and palm stearin in Barnea’s study. 
Therefore, the composition of the HFD may also affect the expression of 
Adipoq in the WAT, although HFD feeding induces obesity regardless of the 
fat composition.                              
 Adipogenesis is driven by a cascade of transcription factors including 
Ppara, Pparg, and Ppargc1a (or PGC-1a). During adipogenesis, Ppara and 
Ppargc1a drive a thermogenic brown or beige phenotype (Peirce V, 2014). 
Ppara mRNA levels were elevated in Adipoq-RD and Adipoq-HFD mice 
compared with WT-RD and WT-HFD mice (p = 0.0007, p < 0.0001; Fig. 3E); 
the levels in WT-CR mice did not statistically differ from those in WT-RD mice 
(p = 0.1265). The level of Pparg mRNA was increased in WT-CR mice 
compared with WT-RD mice; there was no such increase in Adipoq mice (Fig. 
3F). The expression level of Ppargc1a mRNA was significantly elevated in 
Adipoq-RD and Adipoq-HFD and WT-CR mice compared with the respective 
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control groups (p = 0.0068, p < 0.0001, p = 0.0114, respectively; Fig. 3G).  
 In CR mice, fatty acid synthesis is elevated in the WAT within 6 
hours following provision of food, relative to that in the fasting phase, which 
enables the animals to utilize fatty acids as an energy source in the fasting 
phase prior to the next feeding (Bruss, 2010). CR augmented mRNA 
expression levels of a glucose transporter (Glut4, p < 0.0001; Fig. 3H) and a 
fatty acid transporter (Fatp/Slc27a, p < 0.0001; Fig. 3I). In Adipoq mice, 
although there could be an increase in the level of Glut4 mRNA in Adipoq-
HFD compared with that in WT-HFD mice (p = 0.050), this was not significant 
in Adipoq-WT mice (Fig. 3H). Fatp/Slc27a1 mRNA was upregulated in Adipoq 
mice compared with WT mice, particularly in the HFD group (p = 0.0011; Fig. 
3I). Taken together, these results show that some of the genes associated with 
adipogenesis and/or energy metabolism which are regulated by Adipoq 
change in the same direction as is seen in response to CR in mice. 
Because many studies have reported that CR increases the plasma 
concentration of Adipoq in mice and rats (Berg, 2001; Zhu, 2004; Qiao, 2011), 
the present findings emphasize a CR-related protective role for Adipoq in 
insulin resistance and glucose intolerance occurring in high-calorie-induced 
obese animals, as well as in aging animals fed RD. To summarize briefly, the 
present study demonstrated that Adipoq overexpression mimics the 
metabolic effects of CR through down-regulation of p53 in the WAT. The 
findings also suggest that p53 and Adipoq are important factors in the effect 
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of CR on energy metabolism. 
 
3.5. Survival and ER stress in response to endotoxin  
Resistance to a variety of stressors is a hallmark of CR in animals 
(Masoro, 1998). We assessed the survival rate after an inflammatory 
challenge induced by injection of a high dose of lipopolysaccharide (LPS). In 
this experiment, heterozygous Adipoq mice were used. These were generated 
by mating ESTRAP mice with Adipoq mice, and thus enabled us to monitor 
ER stress in vivo. In these mice, the plasma concentration of human Adipoq 
was less than 50% of that seen in mice homozygous for the human ADIPOQ 
gene (Supplemental Table 1). However, the plasma concentration of mouse 
Adipoq was also significantly greater in Adipoq:ESTRAP-RD mice than in 
WT:ESTRAP-RD mice. All WT:ESTRAP-RD mice were found dead within 2.5 
days after LPS injection (Fig. 4A). The survival rates were significantly 
greater in Adipoq:ESTRAP-RD and WT:ESTRAP-CR mice than that in 
WT:ESTRAP-RD mice (p = 0.0009, p = 0.0043 by log-rank test respectively: 
Fig. 4A). The survival rates showed a tendency to be greater in WT:ESTRAP-
CR mice than in Adipoq:ESRTAP-RD mice (p = 0.0628 by log-rank test).  
We also monitored ER stress during the LPS experiment using 
ESTRAP mice (Kitamura M, 2011), because Adipoq is reported to lower ER 
stress and inflammation (Boddu, 2014). In the WT:ESTRAP-RD mice, ER 
stress is known to reduce SEAP activity in serum (Kitamura, 2011). The 
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SEAP activity was sharply reduced between 0 and 8 h after LPS 
administration, at which point it started to increase again, in WT:ESTRAP-
CR and Adipoq:ESTRAP-RD mice (Fig. 4B). However, in WT:ESTRAP-RD 
mice, there was no evidence of a recovery of SEAP activity even after 24 h. 
The SEAP activity was significantly greater in WT:ESTRAP-CR mice than in 
Adipoq:ESTRAP-RD and WT:ESTRAP-RD mice (p = 0.0017, p = 0.0002), 
indicating that ER stress was significantly reduced by CR; the impact of 
Adipoq was minor compared with that of CR. Because the plasma level of 
mouse Adipoq was lower in WT:ESTRAP-CR mice than in Adipoq:ESTRAP-
RD mice (Supplemental Table 1), factors other than Adipoq could be 
attributable to the stress resistance induced by CR. Even though the 
contribution of Adipoq to the stress resistance resulting from CR could be 
minor, the present findings regarding survival rate and SEAP levels suggest 
that Adipoq could play a part in stress resistance in mice. 
 
3.6. Tumor growth 
To test the anti-tumor effect of Adipoq, Lewis lung carcinoma cells 
were subcutaneously implanted in six-month-old mice fed a RD or HFD ad 
libitum. Tumor size and weight were not significantly reduced in Adipoq-RD 
or Adipoq-HFD mice compared with the respective groups of WT mice (Fig. 
5A & B); in contrast, the tumor size and weight appeared to be increased in 
Adipoq-RD mice, compared with WT-RD mice, although this was not 
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statistically significant (p = 0.5273 for tumor size and p = 0.3392 for tumor 
weight; the total number of mice needed to reduce the variance of the tumor 
weights sufficiently to achieve a significant result when α = 0.05 with 50% 
power is estimated to be 84 (thus n = 21 for each group) using a power 
analysis). Thus, we conclude that Adipoq overexpression does not exert the 
anti-tumor effect seen in CR, at least in this allograft model. In the present 
study, the anti-tumor effect of CR was not assessed because of limitations on 
animal use. However, in the allograft model of Lewis lung carcinoma cells, 
reduced calorie intake has been reported to inhibit tumor growth significantly 
(Yakar S, 2006). In tumors formed in the subcutaneous tissue, we measured 
specific receptors for Adipoq, Adipor1 and Adipor2 (Fig. 5C & D). HFD 
decreased Adipor2 mRNA levels in WT and Adipoq mice (p = 0.0367, 0.0158; 
Fig. 5D), but not those of Adipor1 (Fig. 5C). However, there was no difference 
in the expression levels of Adipor1 and Adipor2 between Adipoq and WT mice. 
We also analyzed mRNA expression levels of p16 and p21, downstream 
effectors of the tumor suppressor p53, in the tumor tissues (Fig. 5E & F). 
Adipoq significantly reduced the p16 mRNA expression level in HFD mice (p 
= 0.0152; Fig. 5E) but not in RD mice. Thus, it is unlikely that Adipoq affects 
tumor growth through modulation of Adipor signaling and p16 and/or p21. 
Although genetic variations in the Adipoq gene are reported to be associated 
with increased risk of breast and prostate cancer and decreased risk for 
colorectal cancer, the involvement of Adipoq in lung cancer pathogenesis 
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remains unclear (Ntikoudi, 2014). The present study is limited to an allograft 
model. Thus, the anti-tumor effect of Adipoq should be further investigated. 
 
3.7. Summary  
The present study indicates that Adipoq overexpression mimics the 
metabolic effects and stress resistance induced by CR at least in part, if not 
completely (Table 2). In the present experimental setting, HFD feeding did 
not confound most of the beneficial effects of Adipoq, even compared with RD 
feeding. Regarding the metabolic effects, the present findings suggest the 
sequence of Adipoq, p53, and senescence-like phenotypes in the WAT and 
their involvement in the underlying mechanisms of the anti-aging effect of 
CR. The experiment investigating endotoxin shock also suggests a role for 
Adipoq in the enhancement of stress resistance by CR with amelioration of 







Figure 1. Body weight and food consumption of adiponectin (Adipoq) and wild 
type (WT) mice fed a regular diet (RD) or high-fat diet (HFD) ad libitum. (A) 
The body weight of Adipoq mice and WT mice. The data represent means and 
standard errors (n = 8 or 9). ***, p < 0.001 versus WT-RD as determined by 2f 
ANOVA with Tukey’s HSD test. (B) The average amount of food consumed by 
a single mouse fed a RD. The values were estimated by the total amount of 
food consumed in each cage divided by the number of mice in that cage. The 
data represent means and standard errors (n = 3 or 4 cages). (C) The average 
amount of food consumed by a single mouse fed a HFD. The values were 
estimated by the total amount of food consumed in each cage divided by the 
number of mice in that cage. The data represent means and standard errors 
(n = 3 or 4 cages). (D) The body weight of endoplasmic reticulum (ER) stress-
responsive alkaline phosphatase (ESTRAP) mice. Adipoq:ESTRAP-RD 
represents a group of double transgenic mice for Adipoq and ESTRAP genes 
fed a RD ad libitum. WT:ESTRAP-RD represents a group of wild type mice 
for the Adipoq gene in the ESTRAP background fed a RD ad libitum. WT-
ESTRAP-CR mice were fed a RD at a level 30% less than the average amount 
of food intake in WT:ESTRAP-RD mice. ***, p < 0.001 versus ESTRAP:WT-
RD, as determined by 2f ANOVA with Tukey’s HSD test at individual time 
points. Adipoq:ESTRAP-RD mice weighed slightly less compared with 
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WT:ESTRPA-RD mice (2f ANOVA, p < 0.0001), although there was no 
significant difference between the two groups at individual time points. 
 
Figure 2. Adipoq and CR reduce p53 and p21 expression in the epididymal fat 
tissue as does CR. (A) A representative image of western blotting for p53, p21, 
and control (β-actin) in the epididymal adipose tissue. All blots for the 
quantitative analysis are shown in Supplemental Figure 1. (B) Quantitative 
data of p53 normalized to β-actin. (C) Quantitative data of p21 normalized to 
β-actin. Bars and lines in (B) and (C) represent means and standard errors (n 
= 3). *** p < 0.001 compared with WT-RD, as determined by 1f ANOVA with 
Tukey’s HSD test. ###, p < 0.001 compared with WT-HFD. (D) mRNA 
expression levels of Cd68 normalized to 18S mRNA. (E) mRNA expression 
levels of Ccl2 normalized to 18S mRNA. Bars and lines in (D) and (E) 
represent means and standard errors (n = 8 except for WT-CR (n = 5)). ** p < 
0.01, *** p < 0.001 compared with WT-RD, as determined by 1f ANOVA with 
Tukey’s HSD test. # p < 0.05, ### p < 0.001 compared with WT-HFD. 
 
Figure 3. Adipoq regulates mRNA levels of adipokine, adipogenesis and/or 
metabolism genes in the same directions as changes induced by CR. Data 
represent means and standard errors (n = 8 except for WT-CR (n = 5)). * p < 
0.05, ** p < 0.01, *** p < 0.0001 versus WT-RD, as determined by 1f ANOVA 
with Tukey’s HSD test. & p = 0.05, # p < 0.05, ## p < 0.01, ### p < 0.001 
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compared with WT-HFD. (A) Adipor1, Adiponectin receptor 1. (B) Adipor2, 
Adiponectin receptor 2. (C) Adipoq, mouse adipinectin. (D) Lep, Leptin. (E) 
Ppara, Peroxisome proliferator activated receptor alpha. (F) Pparg, 
Peroxisome proliferator activated receptor gamma. (G) Ppargc1a, Peroxisome 
proliferative activated receptor, gamma, coactivator 1 alpha. (H) Glut4, 
Solute carrier family 2 (facilitated glucose transporter), member 4, (I) 
Fatp/Slc27a1, Solute carrier family 27 (fatty acid transporter), member 1. 
 
Figure 4. Adipoq and CR mice exhibit stress resistance. (A) Survival curves 
after lipopolysaccharide (LPS) injection. Adipoq:ESTRAP-RD and 
WT:ESTRAP-RD mice fed a RD ad libitum. WT:ESTRAP-CR mice fed a 30% 
calorie-restricted RD compared with ad libitum feeding. The initial number 
of mice in each group was 7. ** p < 0.01, *** p < 0.001 versus WT:ESTRAP-
RD, as determined using the log-rank test. Note, p = 0.0628, Adipoq:ESTRAP-
RD vs WT:ESTRAP-CR by log-rank test. (B) Reduction in the rate of secreted 
alkaline phosphatase (SEAP) activity after LPS injection. Data represent 
mean ± SE (n = 7 for each group at 0, 2, 4, 8 h: n = 6 for WT:ESTRAP-RD & 
WT:ESTRAP-CR at 24 h: n = 6 for WT:ESTRAP-CR, n = 7 for 
Adipoq:ESTRAP-RD at 48 h). *** p < 0.001 versus WT: ESTRAP-RD, as 
determined by 2f ANOVA with Tukey’s HSD test using the data between 2 
and 24 h.  
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Figure 5. Adiponectin (Adipoq) does not inhibit tumor growth in the allograft 
model of Lewis lung carcinoma cells. The data represent means and standard 
errors. (A) The wet weight of tumors grown in the subcutaneous tissue (n = 9 
for WT-RD and Adipoq-RD; WT-HFD for n = 10 and n = 8 for Adipoq-HFD). 
(B) Tumor sizes were estimated by the following formula, length × width × 
height × 0.52 (n = 9 for WT-RD and Adipoq-RD; WT-HFD for n = 10 and n = 8 
for Adipoq-HFD). (C) mRNA expression levels of adiponectin receptor 1 
(Adipor1) (n = 6). (D) mRNA expression levels of adiponectin receptor 2 
(Adipor2) (n = 6). * p < 0.05 versus (vs) respective RD groups. (E) mRNA 
expression levels of p16 (n = 6). # p < 0.05 vs WT-HFD group. (F) mRNA 
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Table 1. Blood glucose and insulin concentrations and Quicki in Adipoq and WT mice. 
 
 WT-RD WT-HFD WT-CR Adipoq-RD Adipoq-HFD 
Glucose (mg/dL) 152 ± 6 193 ± 5*** 110 ± 5*** 145 ± 6 135 ± 5### 
Insulin (ng/mL) 1.31 ± 0.13 1.59 ± 0.27 0.58 ± 0.06** 0.70 ± 0.01* 0.39 ± 0.07### 
Quicki 0.271 ± 0.003 0.260 ± 0.005 0.313 ± 0.004*** 0.293 ± 0.002** 0.323 ± 0.007### 
Data represent means ± standard errors (n = 8). * p < 0.05, ** p < 0.01, *** p < 0.001, compared with WT-RD as determined by Tukey’s 
HSD test. ### p < 0.001, compared with WT-HFD. Quicki, quantitative insulin-sensitivity check index (Muniyappa, 2008). 
Adiponectin (Adipoq) and wild type (WT) mice fed a regular diet (RD) or a high-fat diet (HFD) ad libitum. WT-CR, WT 
mice fed a RD diet at a level 30% less than the ad libitum level consumed by WT-RD mice. Blood sampling was 
performed during the fasting phase (refer to the methods section for details). 
Table 2. Summary of study findings; similarities between the effects of 




Insulin sensitivity increase increase 
   Cellular senescence-like changes 
  p53 decrease decrease 
p21 decrease decrease 
proinflammatory cytokines decrease decrease 
   Genes related to energy metabolism in WAT
  Adipoq increase increase 
Adipor1 no change no change 
Adipor2 increase increase 
Lep decrease decrease 
Ppara no change increase 
Pparg increase no change 
Ppargc1a increase increase 
Glut4 increase increase (HFD) 
Fatp/Slc27a1 increase increase (HFD) 
   Stress resistance 
  survival increase increase 
ER stress decrease NS 
   Tumor growth ND no effect 
WAT, white adipose tissue. Increase (HFD), the mRNA was increased in the 
Adipoq-HFD group, but not in the Adipoq-RD group. NS, not significant. ND, 
not determined in the present study. 
 
